<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR16.html">Part 16
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 16.22  Initiation of regulatory hearing.
                            </h3>
                            <p class="depth1"><em>(a)</em> A regulatory hearing is initiated by a notice of opportunity for  hearing from FDA. The notice will--</p><p class="depth2"><em>(1)</em> Be sent by mail, telegram, telex, personal delivery, or any  other mode of written communication;</p><p class="depth2"><em>(2)</em> Specify the facts and the action that are the subject of the  opportunity for a hearing;</p><p class="depth2"><em>(3)</em> State that the notice of opportunity for hearing and the hearing  are governed by this part; and</p><p class="depth2"><em>(4)</em> State the time within which a hearing may be requested, and  state the name, address, and telephone number of the FDA employee to  whom any request for hearing is to be addressed.</p><p class="depth2"><em>(5)</em> Refer to FDA's guideline on electronic media coverage of its  administrative proceedings (21 CFR part 10, subpart C).</p><p class="depth1"><em>(b)</em> A person offered an opportunity for a hearing has the amount of  time specified in the notice, which may not be less than 3 working days  after receipt of the notice, within which to request a hearing. The  request may be filed by mail, telegram, telex, personal delivery, or any  other mode of written communication, addressed to the designated FDA  employee. If no response is filed within that time, the offer is deemed  to have been refused and no hearing will be held.</p><p class="depth1"><em>(c)</em> If a hearing is requested, the Commissioner will designate a  presiding officer, and the hearing will take place at a time and  location agreed upon by the party requesting the hearing, the FDA, and  the presiding officer or, if agreement cannot be reached, at a  reasonable time and location designated by the presiding officer.</p><p class="depth1"><em>(d)</em> A notice of opportunity for hearing under this section will not  operate to delay or stay any administrative action, including  enforcement action by the agency unless the Commissioner, as a matter of  discretion, determines that delay or a stay is in the public interest.  [44 FR 22367, Apr. 13, 1979, as amended at 49 FR 32173, Aug. 13, 1984]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
